| Metric | Q3 2026 | Q3 2025 |
|---|---|---|
| Revenue | 10.8 | 12.4 |
| Gross profit | 8.6 | 9.6 |
| Profit before tax | 0.9 | 1.6 |
| Net income | 1.7 | 1.7 |
| EPS (diluted, $ a share) | $0.01 | $0.01 |
A dash means the filing did not report that period. Growth is not shown when either period was a loss. Figures from the filing's XBRL data.
| Net income, year on year | -2.3% |
|---|---|
| Revenue, year on year | -12.9% |
| Gross margin | 79.4% |
| Operating margin | 5.9% |
Source
Read the filing ↗
10-Q filed with the SEC. Figures from the filing's XBRL data; summary written with AI assistance from the filing.
Vaso Corp: key numbers
- Sector
- Industrial Applications and Services
- Industry
- Electromedical & Electrotherapeutic ApparatusSIC 3845
Today's reference numbers, updated daily. Not a valuation or a recommendation.